Skip to main content
. 2022 Mar 19;107(8):2350–2361. doi: 10.1210/clinem/dgac165

Table 3.

Validation cohort: comparative analysis of reproductive parameters corresponding to single-nucleotide variations rs11031005 and rs10835638

Androl. Parameters rs10835638 rs11031005
Genotype Additive linear model Genotype Additive linear model
GG (n = 803) GT (n = 294) TT (n = 26) P beta TT (n = 831) CT (n = 269) CC (n = 23) P beta
FSH, IU/l (1-7) 5.8 ± 4.9 4.6 ± 3.2 3.6 ± 2.1 5.55e-07** -0.29 (0.06) 5.7 ± 4.8 4.6 ± 3.3 4 ± 2.3 4.71e-06** -0.27 (0.06)
4.4 (1.8-14.2) 3.9 (1.5-10) 3.1 (1.6-8) 4.4 (1.8-14.1) 3.8 (1.5-10.1) 3.1 (1.9-8.7)
LH, IU/l (2-10) 3.6 ± 1.8 3.8 ± 2.3 3.9 ± 1.4 1.63e-01 0.08 (0.06) 3.6 ± 1.8 3.8 ± 2.4 4 ± 1.4 3.64e-02* 0.13 (0.06)
3.2 (1.5-6.6) 3.2 (1.5-7) 3.5 (2.2-6.4) 3.2 (1.5-6.6) 3.2 (1.5-7.2) 3.8 (2.2-6.6)
FSH/LH 1.7 ± 1.2 1.3 ± 0.7 1 ± 0.8 6.4e-12** -0.4 (0.06) 1.7 ± 1.2 1.3 ± 0.6 1.1 ± 0.9 2.08e-12** -0.42 (0.06)
1.4 (0.6-3.6) 1.2 (0.5-2.7) 0.8 (0.5-1.6) 1.4 (0.6-3.6) 1.2 (0.4-2.5) 0.8 (0.5-1.7)
Testosterone, nmol/l (≥ 12) 16.4 ± 6.4 16.2 ± 6.2 18.7 ± 7 8.75e-01 0.01 (0.06) 16.5 ± 6.4 16 ± 6.1 18.2 ± 6.9 7.36e-01 -0.02 (0.06)
15.3 (9.1-27.3) 14.9 (9.2-25.7) 15.6 (11.5-29.1) 15.3 (9.1-27.6) 14.9 (8.9-25) 15.5 (11.4-28.4)
Bitestic. Volume, ml 41.8 ± 14.2 40 ± 13.3 35 ± 13.3 4.93e-03* -0.16 (0.06) 41.8 ± 14.2 39.8 ± 13.2 35 ± 13.7 5.42e-03* -0.17 (0.06)
40 (22-67) 39 (21-64.3) 34 (19.8-52) 40 (22-67) 39 (21-64.6) 34 (19.4-52.6)
Ejaculate volume, ml 3.9 ± 1.6 3.7 ± 1.6 4 ± 1.4 3.04e-01 -0.06 (0.06) 3.9 ± 1.6 3.8 ± 1.6 4.1 ± 1.5 7.9e-01 -0.02 (0.06)
3.6 (1.8-7) 3.4 (1.8-7) 3.9 (1.8-6.8) 3.5 (1.8-7) 3.5 (1.8-7.1) 4 (1.8-6.9)
Total sperm count, Mill/ejac 113.5 ± 169.8 98.6 ± 127.2 108.9 ± 130.8 9.25e-01 -0.01 (0.06) 112.4 ± 168.4 101.2 ± 128.5 103.6 ± 129.1 8.93e-01 0.01 (0.06)
59 (1.9-371.3) 52.5 (3.1-370.3) 51.7 (2.9-365.6) 58.3 (1.9-371.4) 55 (3.1-363) 37.4 (2.9-367.3)
Sperm conc., Mill/ml 30.6 ± 43 28.9 ± 37 32.1 ± 42.9 7.4e-01 0.02 (0.06) 30.5 ± 42.7 29.3 ± 37.6 29.1 ± 40.2 7.36e-01 0.02 (0.06)
17 (0.6-103.1) 15.1 (0.8-108.4) 14.2 (0.7-121.5) 16.9 (0.6-103.4) 15.4 (0.8-109.9) 13 (0.6-95)
Sperm ab-motility, % 43.5 ± 13.2 42.6 ± 13.4 40.5 ± 13.8 1.61e-01 -0.08 (0.06) 43.5 ± 13.2 42.5 ± 13.2 40.2 ± 14 1.31e-01 -0.09 (0.06)
47 (17-59) 46 (17.6-58) 42 (17-57) 47 (17-60) 45 (17-58) 40 (16.4-57)
Sperm morphology 4.4 ± 2.5 4.6 ± 2.7 4.6 ± 2.2 5.09e-01 0.04 (0.06) 4.4 ± 2.5 4.7 ± 2.8 4.5 ± 2.3 3.85e-01 0.06 (0.07)
4 (1-9) 4 (1-10.8) 5 (1-7) 4 (1-9) 4 (1-11) 5 (1-7.3)

Two of the 9 identified single-nucleotide variations (discovery study) were analyzed via reverse transcriptase–polymerase chain reaction in an independent validation cohort (n = 1140 men with idiopathic infertility). Data are presented as mean ± SD and median (5th-95th percentile). Genotype-trait associations are calculated using an additive linear model with age added as a covariate. For sperm parameters, abstinence time was also included as a covariate.

Trends are marked in italics (*P < .05).

Statistically significant associations are marked in bold (**P < 2.50e-03).

Abbreviations: Androl., andrological; Bitestic, bitesticular; conc., concentration; ejac, ejaculation; FSH, follicle-stimulating hormone; LH, luteinizing hormone.